Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes-Reference-Cited by-同舟云学术

Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes

Published:2022-01 Issue:1 Volume:12 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical & Translational All

Author:

Lee Kye Hwa¹^ORCID,Kang Dong Yoon²^ORCID,Kim Hyun Hwa²^ORCID,Kim Yi Jun³^ORCID,Kim Hyo Jung⁴^ORCID,Kim Ju Han⁵^ORCID,Song Eun Young⁶^ORCID,Yun James⁷⁸^ORCID,Kang Hye‐Ryun²⁹^ORCID

Affiliation:

1. Department of Information Medicine Asan Medical Center Seoul South Korea

2. Drug Safety Center Seoul National University Hospital Seoul South Korea

3. Institute of Convergence Medicine Ewha Womans University Mokdong Hospital Seoul South Korea

4. Department of Digital Health Samsung Advanced Institute for Health Science and Technology Sungkyunkwan University Seoul South Korea

5. Seoul National University Biomedical Informatics and Systems Biomedical Informatics Research Center Division of Biomedical Informatics Seoul National University College of Medicine Seoul South Korea

6. Department of Molecular Medicine and Biopharmaceutical Sciences Graduate School of Convergence Science and Technology and College of Medicine Medical Research Center Seoul National University Seoul South Korea

7. Department of Immunology and Rheumatology Nepean Hospital Sydney New South Wales Australia

8. Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia

9. Institute of Allergy and Clinical Immunology Seoul National University Medical Research Center Seoul National University College of Medicine Seoul South Korea

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clt2.12098

Reference47 articles.

1. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience

2. Incidence of Adverse Drug Reactions in Hospitalized Patients

3. Preemptive Genotyping for Personalized Medicine: Design of the Right Drug, Right Dose, Right Time—Using Genomic Data to Individualize Treatment Protocol

4. Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems

5. Preemptive genotyping trialed to prevent adverse drug reactions

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs;Frontiers in Pharmacology;2023-04-26

2. Multiple drugs;Reactions Weekly;2022-12-10

3. Pharmacogenes that demonstrate high association evidence according to CPIC, DPWG, and PharmGKB;Frontiers in Medicine;2022-10-25

4. HLA‐A*24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms in HLA‐B*58:01 carriers in a Korean population; a multicenter cross‐sectional case‐control study;Clinical and Translational Allergy;2022-09